C4 Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $117.2M | $506.8M | $76.1M |
| FY2022 | $141.6M | $430.8M | $29.8M |
| FY2023 | $130.3M | $376.5M | $126.6M |
| FY2024 | $133.6M | $349.6M | $55.5M |
| FY2025 | $102.5M | $359.1M | $74.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $117.2M | $506.8M | $76.1M |
| FY2022 | $141.6M | $430.8M | $29.8M |
| FY2023 | $130.3M | $376.5M | $126.6M |
| FY2024 | $133.6M | $349.6M | $55.5M |
| FY2025 | $102.5M | $359.1M | $74.6M |